Cargando…
Trabectedin use in soft‐tissue sarcoma patients in a real‐world setting: Data from an Italian national drug‐access registry
Trabectedin is a marine‐derived anticancer drug approved for the treatment of patients with advanced soft‐tissue sarcomas (STS). Here, we aimed to analyze its use in a large cohort of STS patients treated in Italy in a real‐world setting. Data on STS patients treated with trabectedin in Italy were p...
Autores principales: | Vincenzi, Bruno, Napolitano, Andrea, Comandone, Alessandro, Sanfilippo, Roberta, Celant, Simone, Olimpieri, Pier P., Di Segni, Susanna, Russo, Pierluigi, Casali, Paolo G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10092104/ https://www.ncbi.nlm.nih.gov/pubmed/36196483 http://dx.doi.org/10.1002/ijc.34309 |
Ejemplares similares
-
Prognostic factors for soft tissue sarcoma patients with lung metastases only who are receiving first‐line chemotherapy: An exploratory, retrospective analysis of the European Organization for Research and Treatment of Cancer‐Soft Tissue and Bone Sarcoma Group (EORTC‐STBSG)
por: Lindner, Lars H., et al.
Publicado: (2018) -
Isolated limb perfusion with biochemotherapy and oncolytic virotherapy combines with radiotherapy and surgery to overcome treatment resistance in an animal model of extremity soft tissue sarcoma
por: Wilkinson, Michelle J., et al.
Publicado: (2016) -
Trabectedin for Patients with Advanced Soft Tissue Sarcoma: A Non-Interventional, Retrospective, Multicenter Study of the Italian Sarcoma Group
por: Palmerini, Emanuela, et al.
Publicado: (2021) -
Clinical outcomes of radio‐hyperthermo‐chemotherapy for soft tissue sarcoma compared to a soft tissue sarcoma registry in Japan: a retrospective matched‐pair cohort study
por: Aiba, Hisaki, et al.
Publicado: (2018) -
Epidemiological study of soft‐tissue sarcomas in Ireland
por: Bhatt, Nikita, et al.
Publicado: (2015)